ArticleHematology. American Society of Hematology. Education Program2023

The optimal management of relapsed and refractory Hodgkin lymphoma: post-brentuximab and checkpoint inhibitor failure.

Natalie S Grover et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.